For individuals who are overweight or obese, losing weight may improve sexual health in several important ways, though responses vary between individuals
For example, in a recent Phase 2 trial, participants lost an average of 15% of their body weight over 12 weeks, a result that exceeds many existing treatments
Here's what retatrutide won't do, regardless of the dose: It won't preserve your muscle mass without intentional effort
Eli Lilly press release: TRIUMPH-1 and TRANSCEND-T2D-1 results presented at ADA 86th Scientific Sessions
This dual mechanism is why some patients who fail methylphenidate respond to amphetamine-class drugs, and vice versa
No standardized dosing, no manufacturing oversight, and no safety data outside controlled clinical trials where every vial and every dose was tracked